File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/IJG.0000000000001397
- Scopus: eid_2-s2.0-85074946946
- PMID: 31702714
- WOS: WOS:000506609500005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Phacoemulsification Versus Phacotrabeculectomy in Primary Angle-closure Glaucoma With Cataract: Long-Term Clinical Outcomes
Title | Phacoemulsification Versus Phacotrabeculectomy in Primary Angle-closure Glaucoma With Cataract: Long-Term Clinical Outcomes |
---|---|
Authors | |
Keywords | Primary angle-closure glaucoma Cataract Phacoemulsification Phacotrabeculectomy |
Issue Date | 2020 |
Publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.glaucomajournal.com |
Citation | Journal of Glaucoma, 2020, v. 29 n. 1, p. 15-23 How to Cite? |
Abstract | Precis:
Phacotrabeculectomy was more effective in reducing intraocular pressure (IOP) and glaucoma drugs than phacoemulsification alone in primary angle-closure glaucoma (PACG) eyes with cataract but was associated with more postoperative complications, up to 5 years after surgery.
Purpose:
The purpose of this study was to compare long-term clinical outcomes of phacoemulsification versus phacotrabeculectomy in PACG eyes with cataract.
Patients and Methods:
The 2 initial prospective randomized controlled trials recruited PACG eyes with cataract using the same criteria and randomized these eyes to receiving either phacoemulsification or phacotrabeculectomy. Clinical data up to 5 years of follow-up were pooled for retrospective analysis.
Results:
Clinical data of 35 patients in the phacoemulsification group and 44 patients in the phacotrabeculectomy group were analyzed. At 5 years after surgery, the mean IOP was decreased by 20.7% and 29.5% from before surgery to 5 years after phacoemulsification and phacotrabeculectomy, respectively (P<0.001 for both groups). Phacotrabeculectomy was significantly more effective than phacoemulsification in reducing IOP up to 5 years after surgery (P<0.001). At 5 years, the mean number of glaucoma drugs required±1 SD was 1.6±1.2 in the phacoemulsification group, and 0.7±1.0 in the phacotrabeculectomy group (P=0.004). Phacotrabeculectomy was associated with more postoperative complications than phacoemulsification up to 5 years (25 complications in the phacotrabeculectomy group versus 6 in the phacoemulsification group, P<0.001).
Conclusions:
Phacoemulsification alone reduces IOP and the need for glaucoma drugs in PACG eyes with cataracts for up to 5 years. Phacotrabeculectomy was more effective in reducing IOP and glaucoma drugs than phacoemulsification alone but was associated with more postoperative complications, up to 5 years after surgery. |
Persistent Identifier | http://hdl.handle.net/10722/285427 |
ISSN | 2023 Impact Factor: 2.0 2023 SCImago Journal Rankings: 0.995 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hansapinyo, L | - |
dc.contributor.author | Choy, BNK | - |
dc.contributor.author | Lai, JSM | - |
dc.contributor.author | Tham, CC | - |
dc.date.accessioned | 2020-08-18T03:53:19Z | - |
dc.date.available | 2020-08-18T03:53:19Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Journal of Glaucoma, 2020, v. 29 n. 1, p. 15-23 | - |
dc.identifier.issn | 1057-0829 | - |
dc.identifier.uri | http://hdl.handle.net/10722/285427 | - |
dc.description.abstract | Precis: Phacotrabeculectomy was more effective in reducing intraocular pressure (IOP) and glaucoma drugs than phacoemulsification alone in primary angle-closure glaucoma (PACG) eyes with cataract but was associated with more postoperative complications, up to 5 years after surgery. Purpose: The purpose of this study was to compare long-term clinical outcomes of phacoemulsification versus phacotrabeculectomy in PACG eyes with cataract. Patients and Methods: The 2 initial prospective randomized controlled trials recruited PACG eyes with cataract using the same criteria and randomized these eyes to receiving either phacoemulsification or phacotrabeculectomy. Clinical data up to 5 years of follow-up were pooled for retrospective analysis. Results: Clinical data of 35 patients in the phacoemulsification group and 44 patients in the phacotrabeculectomy group were analyzed. At 5 years after surgery, the mean IOP was decreased by 20.7% and 29.5% from before surgery to 5 years after phacoemulsification and phacotrabeculectomy, respectively (P<0.001 for both groups). Phacotrabeculectomy was significantly more effective than phacoemulsification in reducing IOP up to 5 years after surgery (P<0.001). At 5 years, the mean number of glaucoma drugs required±1 SD was 1.6±1.2 in the phacoemulsification group, and 0.7±1.0 in the phacotrabeculectomy group (P=0.004). Phacotrabeculectomy was associated with more postoperative complications than phacoemulsification up to 5 years (25 complications in the phacotrabeculectomy group versus 6 in the phacoemulsification group, P<0.001). Conclusions: Phacoemulsification alone reduces IOP and the need for glaucoma drugs in PACG eyes with cataracts for up to 5 years. Phacotrabeculectomy was more effective in reducing IOP and glaucoma drugs than phacoemulsification alone but was associated with more postoperative complications, up to 5 years after surgery. | - |
dc.language | eng | - |
dc.publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.glaucomajournal.com | - |
dc.relation.ispartof | Journal of Glaucoma | - |
dc.subject | Primary angle-closure glaucoma | - |
dc.subject | Cataract | - |
dc.subject | Phacoemulsification | - |
dc.subject | Phacotrabeculectomy | - |
dc.title | Phacoemulsification Versus Phacotrabeculectomy in Primary Angle-closure Glaucoma With Cataract: Long-Term Clinical Outcomes | - |
dc.type | Article | - |
dc.identifier.email | Choy, BNK: bnkchoy@hku.hk | - |
dc.identifier.email | Lai, JSM: laism@hku.hk | - |
dc.identifier.authority | Choy, BNK=rp01795 | - |
dc.identifier.authority | Lai, JSM=rp00295 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1097/IJG.0000000000001397 | - |
dc.identifier.pmid | 31702714 | - |
dc.identifier.scopus | eid_2-s2.0-85074946946 | - |
dc.identifier.hkuros | 312651 | - |
dc.identifier.volume | 29 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 15 | - |
dc.identifier.epage | 23 | - |
dc.identifier.isi | WOS:000506609500005 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 1057-0829 | - |